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Abstract
Objective: The role of needle and syringe sharing behavior of injection drug users (IDUs) in
spreading of blood-borne infections – specially HIV/AIDS – is well known. However, very little is
known in this regard from Iran. The aim of our study was to determine the prevalence and
associates of needle and syringe sharing among Iranian IDUs.
Methods: In a secondary analysis of a sample of drug dependents who were sampled from medical
centers, prisons and streets of the capitals of 29 provinces in the Iran in 2007, 2091 male IDUs
entered. Socio-demographic data, drug use data and high risk behaviors entered to a logistic
regression to determine independent predictors of lifetime needle and syringe sharing.
Results: 749(35.8%) reported lifetime experience of needle and syringe sharing. The likelihood of
lifetime needle and syringe sharing was increased by female gender, being jobless, having illegal
income, drug use by family members, pleasure/enjoyment as causes of first injection, first injection
in roofless and roofed public places, usual injection at groin, usual injection at scrotum, lifetime
experience of nonfatal overdose, and history of arrest in past year and was decreased by being
alone at most injections.
Conclusion: However this data has been extracted from cross-sectional design and we can not
conclude causation, some of the introduced variables with association with needle and syringe
sharing may be used in HIV prevention programs which target reducing syringe sharing among
IDUs.
Introduction
Human Immunodeficiency Virus (HIV)/Acquired Immu-
nodeficiency disorder syndrome (AIDS) has shown a
rapid increasing trend [1]. This problem is closely associ-
ated to injecting drug users (IDUs) in Iran, accounting for
67% of HIV positive cases and 85% of AIDS cases [2].
HIV studies in Iran have underscored the sharing injecting
equipments as the main routes of transmission [3]. In one
study, lifetime and last time needle and syringe sharing
was reported by 50% and 25% of IDUs, respectively [4].
In another study, in a drug treatment sample, more than
two-thirds of the IDUs had shared syringes [5].
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Identifying factors associated with needle and syringe
sharing among IDUs is particularly important for HIV pre-
vention [6]. While very little is known about associated
factors of needle and syringe sharing among Iranian IDUs
[7-9], we here aimed to determine the prevalence and
associates of needle and syringe sharing among a sample
of IDUs in Iran.
Methods
Design and setting
This is a secondary analysis of a cross-sectional survey on
7,743 individuals as a rapid situation assessment (RSA)
performed by the Darius institute. Grant was awarded by
the Iranian Research Center for Substance Use and
Dependence (DARIUS Institute) affiliated to the Univer-
sity of Social Welfare and Rehabilitation Sciences. The
study was approved by the ethical review committee of the
university and informed consent was obtained from all
the participants after they had been verbally reassured that
the information would be kept confidential, especially
from correctional system. This study was conducted under
the financial aid of the Drugs Control Headquarters
(DCHQ). Some other manuscripts have been extracted
from this database.
Samples and sampling
The participants were substance dependent persons
according to DSM-IV and sampled from treatment centers
(n = 1,217), prisons (n = 584) and streets (n = 5,860) of
the capitals of 29 provinces in the Islamic Republic of
Iran. The samples from treatment centers were selected at
random from newcomers. Prisons sampling was also car-
ried out randomly among those who were registered into
the prison within previous 30 days. Snowball approach
was used to take sample from streets. The number of sam-
ples taken from every province was proportional to the
whole population of the province. The sampling started in
April 2007 and lasted for 5 months. This sampling
method is used as the main sampling strategy of drug use
in DCHQ studies.
Process
The interviews were carried out by university graduates
(MS, BS) with drug abuse related majors/degrees who
were dispatched to the provinces after being trained
through workshops in Tehran (the capital of Islamic
Republic of Iran). Each interview took 1 to 1 and a half
hour. Data were collected using paper-based question-
naire namely Inventory for Drug Dependency-IV, which
was the modified version of the one used in the previous
national RSA of Iran performed by the research center
[10]. The revision was done through a series of expert
panel meetings, and new items and questions were added
that met the desired objectives. Sixty nine items were clas-
sified in 9 different parts including: 1) socioeconomic
data (at the time of data collection), 2) family data, 3) first
use data, 4) lifetime drug use, 5) current drug of depend-
ency, 6) injection data, 7) high risk behavior, 8) treatment
data, and 9) social network.
Independent data
Data included in this study included the following parts:
I) socio-demographic data: Data consisted age, age of
beginning addiction, age of beginning injection, duration
of injection, gender, educational level, marital status, liv-
ing place, status of home, status of employment, alone liv-
ing, income, legal income, illegal income, drug sell
income, monthly family income, cigarette smoking, fam-
ily history of cigarette smoking, family history of drug use
II) Drug related data consisted monthly money that IDUs
used for dominant substance, first place of drug use, first
situation of drug use, most reason for first drug use, first
pesrson that who suggested drug use, dominant drug that
current injectors was used(type of drug), poly drug use
and history of drug problems treatment.
III) Injection related data consisted first place of injection,
situation of first injection, cause of first injection, fre-
quency of injection in the past years, usual place of injec-
tion and alone injection.
IV) Non-sexual high risk behaviors consisted of history of
arrest, and history of imprisonment.
To make the final costs internationally comparable, the
costs which were registered in Iranian Rials were con-
verted to purchase power parity or international Dollar
(PPP$). The conversion rate for PPP$ was based on a
recently published Iranian study, which had reached at an
estimation of PPP$ equal to 2727 Rials according to the
information from the Central Bank of Iran and the World
Bank database [11].
Outcome
Lifetime needle and syringe sharing was defined as bor-
rowing or lending syringe, needle or other injection
equipments at least once in their life [12-14]. The most
important cause for needle and syringe sharing was also
included, with a multiple choice question. Answers
included "no access to sterile syringes", "to get more pleas-
ure", "quick injection", "being sure at the shared syring",
"financial limitations", "not aware of possible risk", "easy
injection" and "peer pressure" [15-17].
Statistical analysis
The data obtained in the SPSS for Windows 13 statistical
package. In order to present quantitative data, median
(percentile 25% = Q1 and percentile 75% = Q3), meanHarm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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and standard deviation was used. In order to compare the
qualitative variables between those with and without
"needle and syringe sharing", chi-square test was used.
The comparison of age between two groups was done with
t-test and expenditures of drug use between two groups
with Mann-Whitney. Multivariate stepwise logistic regres-
sion was used to determine the predictors of lifetime
syring sharing. P value < 0.05 was considered significant.
Results
Mean age at study, age at first drug use, age at first injec-
tion, and duration of injection of the participants were
31.3 ± 8.3, 18.6 ± 5.4, 25.9 ± 6.7 and 7.4 ± 6.3, respec-
tively. Most participants were Muslim, lived in urban area,
single, with a lower diploma educational level.
Needle and syringe sharing
From all 2091 IDUs, 749(35.8%) reported lifetime expe-
rience of needle and syringe sharing. Most frequent causes
for needle and syringe sharing included "no access to ster-
ile syringes" (n = 437; 20.9%), "to get more pleasure" (n
= 274; 13.1%), "quick injection" (n = 164; 7.8%), "being
sure at the shared syring" (n = 128; 6.1%), "financial lim-
itations" (n = 128; 6.1%), "not aware of possible risk" (n
= 99; 4.7%), "easy injection" (n = 94; 4.5%) and "peer
pressure" (n = 61; 2.9%).
Associates of Needle and syringe sharing
Socio-demographic data
IDUs with lifetime syring sharing had a higher mean age
(32.3 ± 8.9 vs. 31.4 ± 8.1; p = 0.02), lower age of first drug
use (17.9 ± 5 vs. 18.6 ± 5.4; p = 0.005), higher duration of
injection (6.5 ± 6.3 vs. 5.4 ± 5.5; p < 0.001). Age at first
injection was not linked to lifetime syring sharing (25.8 ±
6.8 vs. 26.1 ± 6.7; p = 0.28). IDUs with lifetime syring
sharing had lower monthly family income (733 ppp$, Q1
= 330 ppp$, Q3 = 1283 ppp$ vs. 807 ppp$, Q1 = 476
ppp$, Q3 = 1466 ppp$; p < 0.001). Overall monthly pai-
ment on drugs were not linked to lifetime syring sharing
(586 ppp$, Q1 = 330 ppp$, Q3 = 1063 ppp$ vs. 550
ppp$, Q1 = 366 ppp$, Q3 = 1100 ppp$; p = 0.44). Bivar-
iate analysis showed that needle and syringe sharing was
significantly higher in females, those who lived in rural
area, those who were illiterate, those who were separate/
divorce/widow, homeless, those who lived alone, those
jobless, those with illegal income, those with drug related
income and those with drug use family members (Table
1).
Substance-related and injection-related data
Needle and syringe sharing was higher in IDUs who used
heroin (331,41.3% vs. 418,32.4%; p < 0.001), was lower
in those who used opioium (47,23.6% vs.702,37.1%; p <
0.001) and was lower in those who used Amphetamines
(12,15.6% vs. 737,36.6%; p <0.001). Poly drug users was
associated with needle and syringe sharing (321, 40.5%
vs. 415, 33.3%; p = 0.001). (Table 2).
Needle and syringe sharing was lower in those who alone
inject (most of times) and home as first place of injection
(Table 3).
High risk behaviors
Lifetime needle and syringe sharing was significantly
higher in those IDU who reported extramarital sexual
relation) 480,64.1% vs. 269,35.9%; p < 0.001), history of
being arrested by police in the past year(507,67.7% vs.
242,32.3%; p < 0.001) and history of imprisonment in
the past year(455,60.7% vs. 294,39.3%; p < 0.001).
Logistic regression
Multivariate logistic regression showed that the likelihood
of lifetime needle and syringe sharing was increased by
female gender(OR = 2.68, 95%CI = 1.25–5.72, p = 0.01),
being jobless (OR = 1.87, 95%CI = 1.41,2.47, p = 0.001),
having illegal income (OR = 1.61, 95%CI = 1.21–2.15, p
< 0.001), drug use by family members (OR = 1.47, 95%CI
= 1.12–1.92, p = 0.005), first drug use in roofless public
place (Odds Ratio = 1.55, 95%CI = 1.15–2.09, p = 0.003),
first drug use in roofed public place (Odds Ratio = 1.62,
95%CI = 1.08–2.42, p = 0.01), pleasure/enjoyment as
causes of first injection (OR = 1.58, 95%CI = 1.2–2.07, p
= 0.001), usual injection at groin(OR = 1.64, 95%CI =
1.11–2.42, p = 0.01), usual injection at scrotum (OR =
1.57, 95%CI = 1.06–2.31, p = 0.02), lifetime experience of
nonfatal overdose (OR = 1.68, 95%CI = 1.28–2.21, p <
0.001), and history of arrest in past year (OR = 1.38,
95%CI = 1.04–1.82, p = 0.02) and was decreased by being
alone at most injections (OR = 0.51, 95%CI = 0.38–0.68,
p < 0.001). (Table 4).
Discussion
In Iran, 1 of 3 IDUs report the history of lifetime needle
and syringe sharing. The likelihood of lifetime needle and
syringe sharing was increased by female gender, being job-
less, having illegal income, drug use by family members,
pleasure/enjoyment as causes of first injection, first injec-
tion in roofless and roofed public places, usual injection
at groin, usual injection at scrotum, lifetime experience of
nonfatal overdose, and history of arrest in past year and
was decreased by being alone at most injections.
Regarding the literature on syring sharing, according to a
study in Mexico, 2005, 80% of the IDUs reported that
they share syringes regularly with other IDUs [18]. In
another study in Canada 27.6% of the participants
reported sharing needles during the past 6 months [12].
Our study showed that needle and syringe sharing was
increased in female IDUs. In line with our finding, oneHarm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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Table 1: The comparison of syringe sharing between socio-demographic variables
Syringe sharing
Count Percent P value
Sex Male 713 35.4% 0.029
Female 35 47.9%
Religious type Muslim 737 36.0% 0.164
other 2 16.7%
Living place Urban 640 35.0% 0.004
Rural 62 47.7%
Education level Illiterate or were barely able to read and write 94 43.7% 0.002
Under diploma 607 36.0%
Upper diploma 35 25.0%
Marital status single 421 38.0% <0.001
Married 166 26.4%
Separate, divorce and widow 153 46.8%
Status of home Having home 575 32.4% 0.000
Homeless 144 62.1
Alone Living No 567 32.8% <0.001
Yes 182 50.6%
Occupation No 353 28.5% <0.001
Yes 396 46.5%
Boss type State 13 25.0% 0.591
Private 114 30.9%
khisfarrma 126 28.5%
Drug Income No 462 30.2% <0.001
Yes 267 52.0%
Job Income No 409 43.1% <0.001
Yes 320 29.3%
Illegal Income No 412 28.5% <0.001
Yes 317 53.0%Harm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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study of gender effect on needle and syringe sharing
bahavior of IDUs showed that females were more likely to
share injecting equipment [19-21]. A recently qualitative
study of Iranian female IDUs reported sharing syringes as
a typical behavior [8]. Different risk profile of HIV among
male and female IDUs is in line with these reports [22].
So, gender should be addressed as an important variable
in needle exchange programs [23].
In our study, jobless IDUs and those who had illegal
income had higher rate of needle and syringe sharing.
Review of literature shows a link between unemployment
of IDUs and needle and syringe sharing behavior [24,25].
Similarly, syringe has been reported to be linked to not
having a legal income [26] or engaging in illegal jobs [27].
These may be due to the financial strains to buy stril
syrings, and free syrings should be given to these IDUs.
In our study, drug injectors with drug user family mem-
bers were at higherrisk for needle and syringe sharing.
Needle and syringe sharing is reported to be higher in
IDUs with a familial network for drug use [28]. Oe study
reported that the role of family network on the needle-
sharing behavior is more severe in women in comparison
with men [29].
In our study, first drug use at public places was linked to
more syringe sharering. According to the literature, IDUs
who usually inject in public places have oppurtunity for
needle and syringe sharing [30,31]. A qualitative study in
Iran also confirms this association [8].
Alone injection in compare to injection with someone
else, is linked to the lack of oppurtiunity of needle and
syringe sharing. In one study in US, markedly lower rates
of needle and syringe sharing was observed in IDUs who
injecting alone [32]. Injection in the context of social and
familial networks is known to be associated with higher
needle and syringe sharing [28]. Those who try to keep
their injecting hidden, may benefit of a reduced risk of
syring sharing [32].
We found that injection in groin and linked to higher nee-
dle and syringe sharing in IDUs. However we did not find
any study in this regard, studies of bodily injection sites of
IDUs have reported a clear progression in sites used, from
the upper extrimities, at initial injection to the use of sites
such as the groin and scrotum the years after [33,34].
Unjection in sites such as the groin and scrotum were
linked to a greater number of injection-related problems.
Legal Non Job Income No 345 35.3% 0.775
Yes 384 36.0%
Furniture sell Income No 683 35.5% 0.483
Yes 46 38.7%
Lifetime smoking Never smoking 23 34.3% 0.636
Current smoking 690 36.1%
Past smoking 36 31.9%
cigarette smoking by parents No 296 29.8% <0.001
Yes 453 41.3%
cigarette smoking by other members of family No 178 26.8% <0.001
Yes 571 40.0%
Substance use by parents No 475 31.3% <0.001
Yes 274 47.7%
Substance use by members of family No 337 29.0% <0.001
Yes 412 44.3%
Table 1: The comparison of syringe sharing between socio-demographic variables (Continued)Harm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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Table 2: The comparison of syringe sharing between drug use-related variables
Syringe sharing P value
Count Percent
Dominant drug usage Opioium Yes 47 23.6% <0.001
No 702 37.1%
Amphetamines Yes 12 15.6% <0.001
No 737 36.6%
Heroin Yes 331 41.3% <0.001
No 418 32.4%
Purified Heroin Yes 202 35.9% 0.943
No 547 35.8%
Norjesic Yes 109 35.6% 0.937
No 640 35.9%
First place of drug use Own home, home of friends, student home 338 32.1% 0.003
Roofless public places 225 40.7%
Roofed public places 95 36.3%
First situation of drug use Specific situations
(family party, friends party, mourning ceremony, gatherings 
with friends)
559 35.5% 0.524
Without Specific situation 187 37.1%
What was the most important event that 
leaded you to first use?
Specific events(work related, familial/domestic, educational) 360 38.6% 0.029
Without Specific event 376 34%
Most important reason for beginning drug use Pleasure/enjoyment, recreation, Konjkavi 402 34% 0.033
Without pleasure/enjoyment 343 38.6%
First person who suggested you to use 
substance
Family or relatives 149 42.2% 0.015
Friends 377 35.5%
Assistants 45 31.5%
Others 52 29.5%
Without mover 96 32.0%Harm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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Table 3: The comparison of syringe sharing between injection-related variables
Syringe sharinge
Number Percent P value
First place of injection Own home, home of friends, student home 382 31.6% 0.003
Roofless public places 206 41.4%
Roofed public places 88 50%
Frequency of injection Lower than once per day 145 31% 0.001
Once and higher per day 573 38.2%
Site of injection Hand No 76 34.4% 0.639
Yes 673 36.0%
Foot No 393 29.9% <0.001
Yes 356 45.8%
Groin No 393 29.9% <0.001
Yes 160 58.4%
Testis No 575 32.1% <0.001
Yes 174 57.6%
Neck No 622 33.4% <0.001
Yes 127 56.2%
Other No 725 35.6% 0.316
Yes 24 42.1%
Cause of first injection Speed of effect No 446 32.9% <0.001
Yes 303 41.2%
pleasure/enjoyment No 404 30.7% <0.001
Yes 345 44.5%
Effect less of before mode of drug use No 526 33.3% <0.001
Yes 223 43.6%
Pry No 589 35.9% 0.864
Yes 160 35.5%
Relief of use No 573 35.2% 0.265
Yes 176 38.0%
Pressure of friends No 610 35.2% 0.208
Yes 139 38.7%Harm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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Substance was not out of reach No 668 35.0% 0.007
Yes 81 45.0%
Low quality of present drugs No 665 34.5% <0.001
Yes 84 52.2%
Lower cost of injection No 603 32.7% <0.001
Yes 146 59.6%
Treatment of addiction No 736 36.2% 0.031
Yes 13 22.4%
Where do you usually inject? Own's home No 375 39.8% 0.001
Yes 374 32.6%
Park No 575 33.3% <0.001
Yes 174 48.1%
School No 743 35.8% 0.436
Yes 6 46.2%
Street and lane No 554 32.2% <0.001
Yes 195 52.2%
"Kharabe" No 385 26.2% <0.001
Yes 364 58.4%
Student's house No 740 35.7% 0.208
Yes 9 50%
Soldiers' camp No 737 35.5% <0.001
Yes 12 80%
Prison No 663 33.5% <0.001
Yes 86 76.8%
Work place No 661 35.5% 0.44
Yes 88 38.1%
Friend's home No 473 34.6% 0.096
Yes 276 38.2%
With whom do you usually inject? Alone 493 33.0% <0.001
With others(friends, relatives) 256 43.0%
Table 3: The comparison of syringe sharing between injection-related variables (Continued)Harm Reduction Journal 2009, 6:21 http://www.harmreductionjournal.com/content/6/1/21
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One study showed a link between more severe drug inject-
ing and share needles [25].
We found a link between needle and syringe sharing and
nonfatal overdose, which are both high risk behaviors.
One study in USA showed that overdosing may be associ-
ated with borrowing syringes [35] but in another study in
England in1994 to 1995 self-reported overdose was not
linked to syring sharing [36]. We also found arrest in the
past year as a associated factor with needle and syringe
sharing. Similar results have been reported by two studies
in Pakistan and Australia [37,38]. Other Risk Behavior
Surveys have shown a Co-occurrence of health-risk behav-
iors among differerent populations [39,40]. These studies
have explained their findings with the gateway theory.
In Iran, evidences show that access to a needle and syringe
program (NSP) will reduce the needle and needle and
syringe sharing practices. The authors suggested NSPs to
be intensified in settings with concentrated HIV epidemics
among IDUs in Iran [13].
There are some limitations to this study. First, this study is
one of a series of secondary analyses [41] and we did not
have data on detail of needle and syringe sharing behav-
iors. Second, the results rely on participants' self-report
data, because self-reports are affected by response bias.
Respondents may tend to deny or underreport their syring
sharing due to social disirability [41]. Third, because of
the cross-sectional design of this study, it is not possible
to draw a conclusion on the direction of the associations.
Endly, in this study we asked lifetime syring sharing, and
we did not limit it by asking sharing during past year or
last injection.
Conclusion
In designing interventions for HIV prevention in Iran,
through decrease of needle and syringe sharing among
IDUs, the introduced variables must be considered. Fur-
ther studies in this regard are needed.
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Table 4: Logestic regression for having syringe sharing between socio-demographic, drug use and injection-related variables in 
intravenous drug users (IDUs)
95% Confidence Interval for odds
P value OR Lower Upper
Gender(female) 1.259 5.725
Jobless <.001 1.870 1.412 2.478
Illegal Income .001 1.617 1.217 2.150
Substance use of family members .005 1.471 1.125 1.925
pleasure/enjoyment as cause of first injection .001 1.583 1.209 2.074
First place of drug use (Roofless public places) .003 1.558 1.157 2.097
First place of drug use (Roofed public places) .019 1.621 1.084 2.424
Alone injection <.001 .515 .388 .682
Groin injection .013 1.642 1.111 2.427
Testis injection .022 1.573 1.068 2.318
Nonfatal overdose <.001 1.686 1.282 2.216
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